A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

AI meets molecular dynamics in Divamics’ latest breakthroughs, accelerating new therapies for complex metabolic conditions.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Conversations with entrepreneurs, technologists, and researchers on emerging technologies and the importance of STEM in drug discovery.

Viruses and bacteria are always trying to sneak into our bodies, but researchers at the University of Missouri are ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT ...

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...

The company’s strategic move will stop financial losses and redirect resources towards drug discovery in antibiotics and ...